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1. Abstract 
T cell adoptive transfer is an important procedure in immunotherapy. In immuno-
compromised patients, T cells may need to be developed from stem cells, requiring the induction of 
Notch signaling events responsible for native T cell differentiation in the thymus. Current methods 
to develop T cells in vitro fail to mimic the 3D thymic niche and are not mechanically tunable. In 
this study, we improve on these approaches with a 2D polymer system with controllable mechanical 
properties, and with a 3D system that more accurately mimics the thymic niche. 3D inverse opal 
poly(ethylene glycol) (PEGDA) scaffolds were fabricated with defined pores using poly(methyl 
methacrylate) microspheres that are soluble in acetic acid, leaving negative space for cell growth. 
The PEGDA surface was made bioactive via biotinylation, followed by a streptavidin linker 
attaching biotinylated Notch ligand Delta-Like Ligand 4 (bDLL4). 2D polyacrylamide gels were 
prepared by sandwiching a pre-polymer droplet between two glass surfaces during redox initiation. 
Mechanical properties were modified by adjusting the concentrations of acrylamide and bis-
acrylamide. Gels were functionalized by immobilizing streptavidin via a SANPAH linker and 
binding bDLL4. After fabricating the systems and demonstrating their chemical and mechanical 
tunability, RT-PCR was used to detect Hes-1 expression, a downstream target of Notch, and flow 
cytometry was used to detect T cell differentiation levels following incubation of T cell progenitors 
with functionalized polymer systems. We show that a) the thymic niche can be effectively mimicked 
by synthetic systems, b) these systems effectively induce Notch signaling, and c) Notch signaling 
results in early T cell differentiation. These data are promising and suggest the potential to develop T 
cell banks from stem cells for the purposes of immunotherapy. 
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2. Background 
2.1 Adoptive Transfer and Medical Motivation 
Cancer immunotherapy is a promising approach in cancer therapeutics. With this 
strategy, the body’s immune cells are trained to attack malignant cells as they would any other 
invader, by educating the effector cells of the immune system to recognize cancer cells are 
foreign and pathogenic. Immunotherapy is an attractive alternative or complement to the current 
paradigm of surgery, radiation, and chemotherapy, as these traditional approaches are very non-
specific and can often be cripplingly painful or uncomfortable for patients. The immune system, 
however, is effective due to its precision and highly amplified response.  
The presence of tumor-infiltrating lymphocytes (TILs) in malignant cancer sites 
underscore the potential for immunotherapy’s efficacy1. High numbers of effector T cells in the 
tumor microenvironment are indicative of a favorable prognosis, demonstrating the role that 
immune cells can play in the reduction of tumor burden1. While the potential therapeutic benefits 
of a strong immune response are clear, however, the tumor microenvironment secretes 
immunosuppressive signals that can inhibit expansion and proliferation of immunological 
effector cells, essentially silencing the immune system1. As a result, medical engineers are 
attempting to strengthen the immune response. One technique already in clinical practice is 
called adoptive transfer. In this technique, T cells from cancer patients are extracted from 
peripheral blood, pulsed with antigen from the tumor microenvironment, and the antigen-specific 
T cells are isolated, expanded, and infused back into the patient2. This method has been 
especially effective in the treatment of melanomas3.  
However, there are several limitations to adoptive transfer4: The procedure requires the 
isolation of peripheral blood, which can be invasive to the patient. Furthermore, expanding T 
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cells ex vivo can be time-consuming, a non-trivial barrier in the case of time-sensitive treatment 
requirements. Perhaps most significantly, however, a patient’s T cells may not be available due 
to severe immunodeficiency, and obtaining T cells from an alternative source poses the 
possibility of host rejection and forces patients to become dependent on long donor waitlists.  
The limitations in the current practice of adoptive transfer therapy combined with 
immunotherapy’s enormous potential creates an urgent need to develop therapeutic banks of 
antigen-specific T cells against various diseases, including cancer. This would allow clinicians to 
reliably access effector cells for the purpose of immunotherapy. Furthermore, to reduce the 
dependence on cell donors, these disease-specific T cells may be derived from stem cells. A 
critical first step in the realization of this vision is the engineering of early-stage immunological 
cells from stem cells. Biomaterials functionalized with biological signals show enormous 
potential in the direction of stem cells down the T cell lineage. The efficacy of this strategy will 
be explored in the studies that follow. 
 
2.2 T Cell Development In Vivo 
 To accurately induce T cell development in vitro for therapeutic purposes, native T cell 
differentiation in vivo must be explored. Hematopoietic stem cells (HSCs) are multipotent stem 
cells that can repopulate all cells of the blood. HSCs initially develop in the bone marrow, but for 
HSCs to progress down the T cell lineage, they must leave the bone marrow and migrate to the 
thymus. There hematopoietic progenitor cells are directed to differentiate into mature T cells5. 
Microenvironments that direct stem cell differentiation down a particular pathway are called 
stem cell niches and can be comprised of several complicated signals that synergize to determine 
a stem cell’s eventual fate6.  
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 Mature T cells are positive for one of two surface protein markers: either CD4 or CD8. 
CD4 single-positive cells are helper T cells that support the immune system via the release of 
cytokines: soluble signals in the immune system that regulate immune responses7. CD8 single-
positive cells are cytotoxic T cells that kill invading pathogens. As HSCs from the bone marrow 
migrate to the thymus, however, they are CD4-CD8-, or double negative (DN) cells5. Upon 
entering the thymus, two main phases comprise the T cell developmental pathway. HSCs arrive 
and congregate in the cortical region of the thymus, where the first phase begins, before moving 
to the medullary segments of the thymus for the second phase5. The two phases are characterized 
by different signaling events and different levels of T cell development. A schematic of these 
steps can be seen in Figure 1. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Simplified schematic of T cell differentiation steps. 
 
 
In the first phase, HSCs undergo Notch signaling and several forms of cytokine signaling 
via stromal cells in the cortex to differentiate into naïve, non-antigen-specific early T cells5. 
Infiltrating DN cells are characterized by two other surface markers: CD25 and CD445. DN 
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developmental stages are traced by measuring the levels of expression of these two markers: the 
first stage of DN development (DN1) is demarcated by a CD25-CD44+ fingerprint, DN2 by 
CD25+CD44+, DN3 by CD25+CD44-, and DN4 by CD25-CD44- 5. At this point, cells begin to 
express CD4 and CD8, or double positive (DP) cells5. Cells throughout this phase also express 
Thy1.2, a T cell marker that is constitutively expressed on all DN cells. Because CD25 is 
transiently expressed in the DN2 and DN3 stages of development, double expression of Thy1.2 
and CD25 is indicative of T cell maturation past the DN1 stage but before the DN4 stage. 
In the second phase of T cell development, DP cells bifurcate into either CD4+ helper T 
cells or CD8+ cytotoxic T cells, also known as single positive (SP) cells5. The fate difference is 
determined by interactions with major histocompatibility complexes (MHCs) on professional 
antigen-presenting cells (APCs) in the thymus5. Early T cells with strong affinity for MHC Type 
1 molecules express CD8 while cells with strong affinity for MHC Type 2 molecules express 
CD45. 
 
2.3 Notch Signaling 
 The goal of this study is to direct the differentiation of HSCs towards a naïve T cell state, 
or through the first phase of the developmental pathway described above. Because of this, the 
key signaling event in the experiments that follow is Notch signaling. Notch signaling is an 
insoluble signaling system. In vivo, the Notch ligand is immobilized to the surface of a cortical 
thymic stromal cell8. Ligands are physically presented on the plasma membrane of the signaling 
cell and sensed by receptor molecules on the plasma membrane of the receiving cell, in this case 
a T cell progenitor8. Notch signaling is present in several embryonic differentiation pathways, 
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and has even been implicated in cancer, but this study focuses on the role of Notch signaling in T 
cell development8,9.  
 In mammals, five Notch ligands have been found to signal via four receptor molecules8. 
The five ligands are Delta-like ligands 1, 2, and 3 (DLL1-3) and Jagged-1 and Jagged-2. All five 
signal through Notch receptors simply named Notch-1 through Notch-48. The Notch receptor is 
composed of both an extracellular region and an intracellular region; the extracellular region 
interacts with Notch ligands while the intracellular region interacts with coactivators in the 
nucleus to influence gene expression, triggering downstream phenotypic effects8. When Notch 
receptors are activated, metalloproteases cleave residues in the extracellular region, and the lost 
fragment is commonly endocytosed by the signaling cell8. This extracellular cleavage event is 
followed by a second cleavage event in the intracellular portion of the receptor, freeing the 
intracellular domain and allowing it to migrate to the nucleus to form a transcription intitiation 
complex with the transcription factor CSL8.  
 In the immune system, Notch signaling is critical to T cell lineage commitment. Notch-1 
inhibits several potential non-T cell differentiation fates for HSCs, including myeloid cells, 
dendritic cells, and B cells8. By inhibiting these cell fate potentials, Notch signaling helps induce 
efficient T cell differentiation. The delta-like ligands, DLL1 and DLL4, have been implicated in 
this process to a greater extent than DLL3 or the Jagged ligands, and data suggest that DLL4 
may be essential to T cell differentiation8. 
 
2.4 Prior Work Towards in vitro T Cell Differentiation 
 Several groups have worked on differentiating T cells in vitro. Two in particular are 
highly relevant to this study’s attempt at artificial Notch ligand presentation. The Zúñiga-
10 
Pflücker group at the University of Toronto obtained a bone marrow stromal cell line called OP9 
cells and transfected them to induce constitutive DLL1 expression. The modified cell line was 
named OP9-DL110. Studies have shown that growing HSCs in the presence of these Notch 
ligand-presenting stromal cells effectively directed the cells through the DN stages and formed 
DPs, even resulting in the development of CD8+ SP cells, although not CD4+ SP cells10. Without 
the artificial introduction of Notch ligand, however, non-T cell lineages develop, whereas when 
DLL1 is transduced, T cells develop at the expense of these other fates, demonstrating the 
expected role of the Notch ligand10. 
 For clinical purposes, however, it is desirable to create a stromal cell-free differentiation 
system. Ideally, T cells that develop should not come in contact with any other cell source—
especially not an immortalized cell line—to avoid the risk of contamination. For this reason, 
other groups have focused on developing stromal-free T cell differentiation systems. One notable 
example of this is the Varnum-Finney group. There, researchers identified a set of soluble 
cytokine signals that synergize with insoluble Notch ligand presentation on tissue culture-treated 
polystyrene to direct T cell differentiation11. Instead of relying on stromal cells for DLL1 
presentation, tissue culture wells were treated with an antihuman IgG antibody, blocked with 
bovine serum albumin (BSA), and incubated with DLL1-IgG, a construct in which an IgG 
domain was attached to the ligand to allow for binding with the receiving antibody in the tissue 
culture dish11. In addition, the group identified a defined set of cytokines to induce 
differentiation: murine stem cell factor (SCF), human Flt-3 ligand (hFlt3-l), human IL-6 (hIL-6), 
and human IL-7 (hIL-7) at 100 ng/mL, and human IL-11 (hIL-11) at 10 ng/mL. The group saw a 
significant increase in Thy+CD25+ cells in conditions with Notch signaling. 
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2.5 This Study’s Approaches and Potential Benefits Over Prior Work 
 From the standpoint of tissue engineering, there are several potential issues with the in 
vitro systems described above. First, the T cell differentiation methods outlined above are all in 
two-dimensional culture conditions, while the thymic niche is a complex three-dimensional 
environment where relative spatial orientation is critical, such as the relationship between the 
cortical and medullary regions of the thymus5. Furthermore, studies have indicated that even if 
components of the thymus are isolated, they must reaggregate into a three-dimensional structure 
to effectively induce T cell differentiation5. Even if three-dimensional environments are not 
essential, however, it is reasonable to hypothesize that three-dimensional ligand-presentation 
environments will more efficiently expose cells to Notch signals. 
 Another concern with previous attempts at in vitro T cell differentiation is that they are 
both carried out on hard tissue culture-treated plastic. These environments have significantly less 
compliance than the thymus. Recently, studies have identified the mechanical microenvironment 
to be critical to the detection of a stem cell niche. Pioneering work done by the Engler group at 
the University of California, San Diego has demonstrated that mesenchymal stem cells will 
differentiate into bone, muscle, or neuronal cells based exclusively on the stiffness of the 
substrate on which they are grown12. Thus, engineering the stem cell niche must take into 
account both the chemical microenvironment—by introducing the correct cocktail of cytokines 
and Notch signals—and the mechanical microenvironment—by striving to mimic the mechanical 
compliance of the thymus. 
 In this study, two novel independent methods of in vitro T cell differentiation are 
presented. One solves the problem of two-dimensionality while the other solves the problem of 
mechanical stiffness. Three-dimensional inverse opal (IO) scaffolds with highly ordered pores 
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for cell residence were developed from poly(ethylene glycol) diacrylate (PEGDA) and 
functionalized with Notch ligands to direct T cell differentiation in three dimensions. Two-
dimensional polymer gels were made of polyacrylamide (PA) and similarly functionlized with 
Notch ligands to induce T cell differentiation, but the ratios of the acrylamide and bis-acrylamide 
monomers could be fine-tuned to fabricate gels with a specific elasticity. By analyzing these 
systems, the roles of three-dimensionality and substrate stiffness in T cell differentiation could be 
independently analyzed. 
 This project consisted of three main phases: 1) each polymer system was fabricated and 
characterized both chemically and mechanically; 2) mouse HSCs were incubated with these 
systems in the short term and analyzed for Notch signal induction; 3) mouse HSCs were 
incubated with these systems in the long term and analyzed for T cell differentiation efficiency.  
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3. Materials and Methods 
3.1 Fabrication of PEGDA IO Scaffolds 
 PEGDA scaffolds were prepared based on a modified protocol developed by the Irvine 
group13. 100 µm poly(methyl methacrylate) (PMMA, Fluka) microparticles were suspended at 
60% w/w. Microsphere suspension was slowly added at 20 µl increments to PDMS molds 
shaking at 280 rpm to allow the microspheres to settle into a crystalline lattice shape while the 
ethanol evaporated. 40% PEGDA solutions were prepared with PEG-diacrylate and biotin-PEG 
acryl, added at 500:1 PEG:biotin molar ratios, using Irgacure 2959 (Ciba) at 0.05% w/w as the 
photoinitiator. 20 µl of the prepolymer solution were added to the microsphere structures and 
constructs spun down at 1500 rpm for three minutes to allow polymer solution to infiltrate 
between the packed microspheres. Gels were formed under UV radiation for eight minutes. The 
scaffolds were then incubated in 100% acetic acid for three days, to dissolve the PMMA 
microspheres, replacing with fresh acid every two to four hours initially and then every day. 
Scaffolds were then transferred to sterile PBS and washed several times before use. These steps 
are outlined in Figure 2 below. 
 
 
 
 
 
 
 
Figure 2. Steps in PEGDA IO scaffold fabrication 
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3.2 Fabrication of PA Gels 
 2D PA gels were fabricated based on the protocol developed by Tse, et al14. Thin, 
hydrophilic gel disks were polymerized between hydrophilic glass coverslips and hydrophobic 
glass slides, allowing the disks to adhere to the coverslips and to be easily removed from the 
slides, as seen in Figure 3. Circular glass coverslips were made hydrophilic via amino-silanation. 
Coverslips were treated with 0.1 M sodium hydroxide (NaOH) in water. Solvent was evaporated 
with heat, leaving a uniform residue of NaOH. Free ions were treated with 
aminopropyltriethoxysilane (APES, Acros Organics). Frosted glass slides were made 
hydrophobic via treatment with dichlorodimethylsilane (DCDMS, Acros Organics). Acrylamide 
and n,n’ methylene-bis-acrylamide (Sigma-Aldrich) were polymerized using redox chemistry 
initiated by 1/1000 volume of n,n,n’,n’-tetramethylethylenediamine (TEMED, Sigma-Aldrich) 
and 1/100 volume of 10% ammonium persulfate (APS, Sigma-Aldrich). Acrylamide and bis-
acrylamide were added at 100:1 ratios. During polymerization, 25 µl droplets were sandwiched 
between the coverslip and slides and allowed to crosslink for thirty minutes at room temperature 
before removal. Gels were subsequently washed twice with PBS to remove unpolymerized 
acrylamide, which can be toxic to cells.  
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Figure 3. Polymerizing PA between two modified glass surfaces 
 
 
3.3 Ligand Biotinylation 
 Mouse DLL4 obtained from R&D Systems was conjugated to biotin using the Biotin-XX 
Microscale Protein Labeling Kit (Life Technologies). Biotin-XX-succinimidyl ester was 
incubated in a sodium bicarbonate buffer solution for fifteen minutes, and unbound biotin was 
removed via a resin in a centrifugal filter. This was done to prevent free biotin from out-
competing biotinylated DLL4 (bDLL4) and rapidly binding streptavidin sites on polymer 
surfaces during functionalization. The yield of the reaction was determined using absorbance on 
a plate reader (BioTek).  
 
3.4 Functionalization of Tissue Culture Plates 
 Hard tissue culture plates were used as controls against which soft polymer substrates 
could be compared. Tissue culture plates were bound with ligand using methods similar to those 
described by Varnum-Finney11. 48-well plates were incubated in 150 µl of 10 µg/mL streptavidin 
(Promega) for thirty minutes at 37ºC. Wells were then washed twice with PBS and blocked with 
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Hank’s Balanced Salt Solution (HBSS, Gibco) + 2% BSA for thirty minutes at room 
temperature, and washed twice upon completion of the incubation period. Finally, wells were 
incubated with 150 µl of bDLL4 at the desired concentration, followed by two more PBS 
washes. 
 
3.5 Functionalization of PEGDA IO Scaffolds 
 Biotinylated scaffold constructs were placed in 1.5 mL low-adhesion tubes and incubated 
with 500 µl of 5 µg/mL streptavidin solution overnight at 4ºC. Unbound streptavidin was washed 
twice with PBS for twenty-four hours at 4ºC and then incubated with 500 µl of the desired 
bDLL4 concentration in low-adhesion tubes overnight at 4ºC. Two more PBS washes followed 
to remove unbound bDLL4. A schematic of the final chemical linkages in this functionalization 
scheme can be seen in Figure 4. 
 
3.6 Conjugation of Streptavidin and SANPAH 
 N-Sulfosuccinimidyl-6-(4’-azido-2’-nitrophenylamino) hexanoate (sulfo-SANPAH, 
Pierce) is a common reagent to bind free amine groups on polyacrylamide with a 
photoactivatable nitrophenyl azide, and was thus used to functionalize the surface of 2D PA gels. 
An N-hydroxysuccinimide (NHS) ester that reacts with amino groups on proteins was used to 
conjugate streptavidin to sulfo-SANPAH to form streptavidin-SANPAH. Streptavidin was 
incubated with sulfo-SANPAH at room temperature for three hours, and unconjugated SANPAH 
removed via centrifugal filtration. 
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3.7 Functionalization of 2D PA Gels 
Sulfo-SANPAH was used to attach streptavidin to gels by photo-crosslinking SANPAH 
to amines on the acrylamide backbone. 150 µl of streptavidin-SANPAH solution at 5 µg/mL 
were exposed to UV radiation for ten minutes. Modified gels remained on their glass coverslips, 
and fit into 24-well plates that were outfitted with PDMS molds to fit the dimensions of the 
coverslip. Following two PBS washing steps, streptavidin-modified gels were incubated with 
200 µl of solution at the desired concentration of bDLL4 at 4ºC overnight, and again washed 
twice in PBS before cell seeding to remove unbound ligand. The chemical presentation scheme 
is outlined in Figure 4 below. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Ligand presentation schemes for both 2D and 3D systems 
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3.8 Ligand Density Studies 
 Ligand density was measured indirectly. BSA tagged with biotin and fluorescein (biotin-
BSA-FITC, Nanocs) was used as a model for bDLL4 due their to similar molecular weights. 
Biotin-BSA-FITC was bound in an identical manner and concentration as bDLL4 to all 
streptavidin-modified in vitro systems. Three PBS washes were collected and analyzed on a 
fluorescent plate reader (Biotek) against a biotin-BSA-FITC standard curve to determine the 
mass of biotin-BSA-FITC remaining unbound. This was subtracted from the total probe added to 
determine the density of bound model protein.  
 
3.9 Rheology 
 The mechanical properties of hydrogels and tissues were determined using a rheometer 
(Anton Paar Physica MCR 101) utilizing a 7.974 mm diameter oscillatory measuring system. 
Measurements were taken at room temperature with a 1 Hz frequency and 5% strain, as these 
conditions were in the linear regions of representative frequency and amplitude sweeps for all 
material types. Gap sizes were chosen to approximately equalize initial compression across all 
samples. Thymus samples were obtained from BALB/c mice (Jackson Laboratory), PEGDA gel 
samples were photopolymerized in PDMS templates, and PA gel samples were polymerized in 8 
mm silicone isolators. The storage moduli were compared between materials and tissue samples 
to determine relative mechanical properties. 
 
3.10 HSC Isolation 
 Primary HSCs were isolated from four to six week old BALB/c mice (Jackson 
Laboratory). Mice were euthanized and legs were dissected and de-fleshed to collect the femur 
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and tibia. Bone tips were cut and the bone marrow flushed with PBS into a conical tube using a 
21-gauge needle. Cells were suspended via repeated aspirations through a 16-gauge needle. Any 
remaining flesh or bone debris was removed by straining through 40 µm cell strainers, and red 
blood cells were lysed using a red blood cell lysis buffer (eBioscience). Hematopoietic cells 
already committed to a mature lineage were removed using magnetic-activated cell sorting 
(MACS). Cells were stained with a cocktail of antibodies bound to magnetic beads that identify 
mature cell markers using a mouse lineage depletion kit (Miltenyi Biotec) and these cells were 
captured on a magnetic column. Lineage negative cells were stained with anti-cKit APC and 
anti-sca1 PE antibodies (eBioscience) and sorted for double positive cells on a BD FACS Aria II 
(Beckton Dickinson) to select for lin-ckit+sca1+ cells, markers characteristic of HSCs. 
 
3.11 Notch Signaling Studies 
 Cells were seeded onto 48-well plates, 2D PA gels, or 3D PEGDA gels and cultured with 
IMDM (HyClone) with 20% FBS (Stem Cell Technologies) and the cytokine cocktail previously 
described by the Varnum-Finney group11: SCF, hFlt3-l, hIL-6, and hIL-7 at 100 ng/mL and hIL-
11 at 10 ng/mL. Cells were loaded onto PEGDA gels by adding 15 µl of cell suspension onto the 
hydrogel surface and spinning at 800 rpm for one minute at 4ºC. After three hours in culture, 
cells were removed with two rounds of vigorous PBS washes. RNA was isolated using the 
RNeasy Plus Micro Kit (Qiagen), and the mass of isolated RNA was quantified using the Quant-
iT RiboGreen RNA Kit (Life Technologies). Reverse transcription was performed using 
Superscript II First Strand Synthesis System for RT-PCR (Life Technogies). Levels of Hes-1, a 
downstream target of Notch signaling, were used to determine whether the functionalized 
substrates had induced Notch signaling. Hes-1 expression was measured using quantitative real 
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time PCR (RT-PCR). An ABI Prism 7900HT Real Time PCR System measured the fluorescence 
emitted by dyes in the RT2 SYBR Green/ROX qPCR Mastermix (SA Biosciences). Hes-1 levels 
were normalized against β-actin levels, a gene that is constitutively expressed. The 2-ΔΔCt method 
was used to determine fold differences in Hes-1 levels between samples. 
 
3.12 Differentiation Studies 
 Differentiation studies were performed only in 48-well plates and in 2D PA gels. 1,000 
lin-ckit+sca1+ cells were seeded onto the substrates in the same media used for the Notch 
signaling studies. Media was replaced along with fresh cytokines every three to four days by 
gently aspirating out media without disturbing cells resting on the substrate floor. Fresh 
cytokines were added such that their total concentration matched the levels described above. If 
culture became too confluent, 4/5 of the cells were removed and discarded. 
 On day nine of culture, the differentiation state of the cells was measured using flow 
cytometry. Cells were suspended in FACS buffer (PBS + 2% FBS + 0.1% NaN3 + 2 mM 
EDTA). Non-specific binding was avoided by incubating with Fc Block (BD Pharmingen) at 4ºC 
for five minutes. Cells were then stained with three antibodies: anti-CD25 Alexafluor 488, anti-
CD44 PE, and anti-Thy1.2 APC (eBioscience). In addition, a live/dead stain (7-AAD, 
eBioscience) was added to differentiate viable from dead cells during the analysis. Antibody 
incubation proceeded for thirty minutes at 4ºC wrapped in foil. Cells were washed once in FACS 
buffer and flow cytometry was performed on an Accuri machine (Beckton Dickinson). Cells 
were isotype-stained as negative controls, and single-stained samples were used to optimize 
compensation values. The presence of Thy1.2+CD25+ double positive cells indicated either the 
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DN2 or DN3 stage of development and their abundance was used to quantify T cell 
differentiation.  
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4. Results 
4.1 High surface area scaffolds can be fabricated 
 One concern while developing 3D porous materials is maintaining pore integrity. If pore 
sizes are too large or if the material is too soft and compressible, pores tend to collapse, 
disturbing the controlled cellular microenvironment. The stiffness obtained with 40% PEGDA 
gels, however, was sufficient to prevent the collapsing of the pores. Surface area calculations 
indicate a highly spatially efficient substrate. The entire scaffold has a volume on the order of 
millimeters cubed, but has a surface area of 80.2 cm2. This is greater than the area of T75 tissue 
culture flasks that are commonly used in culture. 
 
4.2 Ligand density can be effectively controlled on well plates and 2D PA gels 
 Ligand density was measured using the indirect techniques described in the methods 
section. Biotin-BSA-FITC was incubated on either 48-well plates or 2D PA gels at a low 
concentration (2 µg/mL), moderate concentration (5 µg/mL), or high concentration (10 µg/mL). 
These were compared against a negative control with no fluorophore. A dose-dependence was 
observed on both hard tissue culture well plates and on 2D PA gels. The surface areas of the well 
plates and PA gel surfaces were calculated and used to determine ligand density in units of molar 
density of probe per area (pmol/cm2). The data are displayed in Figure 5. Wells in 48-well plates 
had molar densities of 0.96 ± 0.31 pmol/cm2, 2.0 ± 0.6 pmol/cm2, and 2.9 ± 0.6 pmol/cm2 at low, 
moderate, and high concentrations, respectively. Gels had molar densities of 4.4 ± 0.3 pmol/cm2, 
7.5 ± 0.5 pmol/cm2, and 13.3 ± 0.4 pmol/cm2 at low, moderate, and high concentrations, 
respectively. Gels were able to bind more biotin-BSA-FITC than hard tissue culture wells, but a 
dose-dependency was observed on both substrates. 
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Figure 5. PA ligand density. Increasing ligand model protein  
incubation concentration increases final immobilized density. 
* indicates p<0.05 
 
4.3 Ligand density is independent of acrylamide concentration 
 One concern was that ligand density and mechanical properties could not be tuned 
independently. Because acrylamide concentrations were found to correlate with mechanical 
properties, gels with different levels of acrylamide concentration were incubated with low and 
high concentrations of biotin-BSA-FITC to determine whether there were significant differences 
in density that resulted from different acrylamide concentrations. Gels with low concentration 
(3% acrylamide, 0.03% bis-acrylamide), moderate concentration (4% acrylamide, 0.04% bis-
acrylamide), and high concentration (10% acrylamide, 0.1% bis-acrylamide) of polymer were 
functionalized with biotin-BSA-FITC at low concentrations (2 µg/mL) and high concentrations 
(10 µg/mL) of ligand model protein. No statistical differences were found between the different 
stiffnesses, as seen in Figure 6. 
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Figure 6. Independence of ligand density and material stiffness. The final  
immobilized ligand density is independent of acrylamide percentage. 
* indicates p<0.05 
 
4.4 Streptavidin density can be effectively controlled on PEGDA IO scaffolds 
 Ligand density was again measured using the indirect method. Problems in the sensitivity 
of the assay prevented accurate measurements for the final biotinylated probe. Instead, 
biotinylated PEGDA scaffolds were incubated in 1 mL of solution with incrementally increasing 
streptavidin-PE concentration. The data are shown in Figure 7. Scaffolds incubated with 1 
µg/mL streptavidin-PE bound 0.0045 ± 0.0056 pmol/cm2. Gels incubated with the next lowest 
concentration (2 µg/mL) bound 0.027 ± 0.006 pmol/cm2. Scaffolds incubated with 3 µg/mL 
streptavidin-PE bound 0.034 ± 0.007 pmol/cm2, while the highest concentration (4 µg/mL) 
yielded the highest density (0.053 ± 0.008 pmol/cm2). All increasing concentrations resulted in 
significantly higher densities than that of scaffolds incubated with only 1 µg/mL streptavidin-PE. 
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Figure 7. PEGDA IO ligand density. Increasing cross-linker model protein  
incubation concentration increases final immobilized density. * indicates p<0.05 
 
4.4 Rheology is an effective measure of mechanical properties for tissues and soft substrates 
 Rheology optimization requires determining a strain (%) and frequency (Hz) of 
oscillation that provide linear storage modulus curves for all substrates examined. In this study, 
five substrates were examined: mouse thymuses, 3% PA gels, 4% PA gels, 5% PA gels, 10% PA 
gels, and 40% PEGDA gels. A sweep from 0.1% to 10% strain at 1 Hz and a sweep from 0.1 to 
10 Hz at 5% strain were performed. The strain sweep was linear at 5% strain and the frequency 
sweep was linear at 1 Hz for all materials, both synthetic and native, as seen in Figure 8. Thus, 
all rheological studies performed were executed with 5% strain and 1 Hz. 
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Figure 8. Frequency and strain sweeps for rheology  
optimization. A 1 Hz, 5% strain protocol is linear for all samples. 
 
 
4.6 4% acrylamide, 0.04% bis-acrylamide PA gels mimic the thymus 
 Rheological data is visualized in Figure 9. The thymus was found to have a storage 
modulus of 110 ± 30 Pa. A 40% bulk PEGDA gel with no pores had a storage modulus of 7300 
± 3500 Pa. PA gels decreased with decreasing concentrations of acrylamide. 10% PA gels had a 
storage modulus of 5100 ± 4400 Pa; 5% PA gels had a storage modulus of 220 ± 66 Pa; 4% PA 
gels had a storage modulus of 120 ± 35 Pa; 3% PA gels had a storage modulus of 3.3 ± 3.4 Pa. 
T-tests were performed comparing the storage modulus of the synthetic materials to that of the 
thymus. 40% PEGDA and 10% PA were both significantly stiffer than the thymus while 3% PA 
was significantly softer. Both 5% and 4% PA gels were not statistically different from the 
thymus, but 4% gels had an average storage modulus closer to that of the thymus. For all 
subsequent experiments, 4% gels were used to mimic the mechanical microenvironment of the 
thymus. 
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Figure 9. Rheological properties of substrates. 4% PA gels mimic the thymus. 
 
4.7 PEGDA IO scaffolds induce Notch signaling with dose dependency 
 Hes-1 gene expression was measured using RT-PCR. PEGDA IO gels were fabricated 
and functionalized with low and high concentrations of Notch ligand (2 µg/mL and 10 µg/mL, 
respectively). Following three hours of culture, levels of Hes-1 expression were found to be 
dose-dependent on the density of ligand bound, as seen in Figure 10. Levels of expression were 
compared against plain scaffold unmodified with DLL4, and normalized to calculate the fold 
change in Hes-1 expression. Cells seeded in scaffolds with low ligand density had a 1.9 ± 0.8 
fold increase in Hes-1 expression while cells in scaffolds with high ligand density experienced a 
2.9 ± 0.4 fold increase. The large standard deviation in the low-density scaffold data made the 
fold increase insignificant. However, results at 10 µg/mL demonstrated a significant increase in 
Notch signaling in the presence of a high concentration of immobilized bDLL4.  
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Figure 10. Hes-1 gene expression in PEGDA IO scaffolds. Increasing  
ligand density results in increasing levels of Notch signaling.  
* indicates p<0.05. 
  
4.8 Soft PA gels induce latent Notch signaling 
 RT-PCR with cells seeded on 2D PA gels revealed interesting patterns in Notch 
signaling, as seen in Figure 11. Hes-1 expression data was normalized against untreated well 
plates. Well plates treated with low and high concentrations of bDLL4 (2 µg/mL and 10 µg/mL, 
respectively) to demonstrate the effectiveness of immobilized Notch signaling in 2D. Wells 
modified with low concentrations of bDLL4 showed a significant increase in gene expression 
with a 2.8 ± 0.8 fold increase in Hes-1 expression. Furthermore, a significant increase in Hes-1 
expression was detected in 10% gels treated with a high concentration of bDLL4, with a 1.8 ± 
0.2 fold increase in Hes-1 expression. Interestingly, non-functionalized soft 4% and 10% 
surfaces also showed an increase in gene expression, although they were not bound with 
signaling ligand. 4% gels exhibited a fold increase of 2.3 ± 0.5 in levels of Hes-1 and 10% gels 
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displayed a fold increase of 1.9 ± 0.6 in levels of Hes-1. Only the 4% gels, however, had an 
increase in Hes-1 gene expression that was statistically significant. 
 
 
 
 
 
 
 
 
 
Figure 11. Hes-1 gene expression in 2D PA gels. No clear link between  
binding density and gene expression can be seen. However, there is some  
latent Hes-1 expression in 4% gels. * indicates p<0.05. 
 
 
4.9 PA gels induce early T cell differentiation after nine days of culture  
 The fraction of cells with a Thy1.2+CD25+ double-positive phenotype was measured after 
nine days in culture. The percentage of cells was relatively low, less than 5%, and due to large 
standard deviations, means and statistical analysis did not yield statistically significant results. 
Thus, a representative flow cytometry plot is shown below in Figure 12 that demonstrates the 
common trends. In well plates, cells cultured on substrates with no ligand or with low 
concentration of ligand (2 µg/mL) exhibited low levels of differentiation, and less than 1% of the 
cells were Thy1.2+CD25+. Plates with high density (10 µg/mL), however, showed 3.83% 
differentiation efficiency. 4% and 10% PA gels both induced a higher degree of differentiation in 
low DLL4 density conditions, with 1.11% and 2.94% fractions of double-positive cells. Gels 
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with high DLL4 densities exhibited 3.03% differentiation in 4% gels and 3.76% differentiation 
in 10% gels. 
 
Figure 12. Induced differentiation on PA gels. Thy1.2+CD25+  
cells are considered early T cells. 
 
 
31 
5. Discussion 
 In adoptive transfer therapy, autologous T cells are expanded ex vivo, pulsed with 
antigen, and re-infused back into the patient in the hopes that these T cells will help the patient 
defend against an invasive pathogen or malignant tumor2–4. However, if the patient is severely 
immunocompromised, finding sufficient T cells to culture ex vivo may be challenging if not 
impossible. Perhaps even more significantly, expanding and maturing T cells in the laboratory 
can be extremely time-consuming, and waiting for T cell growth in imperfect laboratory 
conditions is a luxury that patients suffering from life-threatening diseases may not have. 
Because of this, there is an urgent need to have T cell banks on store for patients in case they 
become severely immunocompromised or need immediate immunotherapy to defend against an 
infiltrating pathogen.  
 Stem cells are an attractive source from which to develop these banks because of their 
differentiating potential and tendency to self-replicate, providing a potentially steady and 
constant source of T cells. The field of tissue engineering has made great strides in the past 
decades regarding optimal conditions to induce stem cell differentiation. Engineers have utilized 
the idea of bio-mimicry to as accurately as possible replicate the conditions of the native tissue in 
synthetic system, with the hypothesis that stem cells sense their local niche to determine towards 
which lineage they should differentiate. To this end, tissue engineers have fabricated elaborate 
three-dimensional systems that present growth factors and signals to cells occupying carefully 
designed pores, because cells grow in three-dimensions in the body, and not on flat surfaces. 
Similarly, engineers have concluded that the mechanical properties of a stem cells’ 
microenvironment also contribute to the stem cell niche, and cells will differentiate into different 
types of cells depending on the stiffness and compliance of the substrate on which they reside12.  
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 The development of a precisely-designed spatial, chemical, and mechanical 
microenvironment for differentiation appears particularly critical in T cell differentiation. T cells 
natively develop in the thymus, an organ with an elaborate three-dimensional architecture. There 
are distinct cortical and medullar regions, each of which are responsible for different stages in 
the T cell developmental pathway. Thus, it is reasonable to believe that a three-dimensional 
environment could be substantially more efficient at inducing T cell differentiation than a flat 
surface more traditionally used in cell culture techniques.  
In addition, the chemical microenvironment of the T cell differentiation scheme must be 
finely tunable. Immunologists have elucidated several factors in the differentiation pathway, but 
one of the most critical is an immobilized Notch ligand, such as DLL4, that blocks B cell 
differentiation and thus promotes T cell differentiation instead. Any substrate capable of 
directing stem cells toward the T cell lineage must thus be capable of immobilizing these ligands.  
 Furthermore, the mechanical environment must be finely tuned. One of the prevailing 
hypotheses describing the mechanism for a cell’s sensing of its mechanical microenvironment is 
that mechanosensors in the cytoskeleton of a cell pull on the extracullular substrate12. If the 
substrate is non-compliant and tugs back with a force that is too great, the mechanotransducing 
structure can unfold, making it non-functional. On the other hand, if the substrate is too soft, the 
mechanosensor remains in a conformation that obscures its active site, also making it non-
functional. Only if the substrate is ideally compliant will the mechanosensor remain natively 
folded but with an exposed active site, facilitating down-stream signaling events. While HSCs 
are non-adherent cells and thus do not exchange forces with a permanent substrate with defined 
mechanical properties, they do come into contact with a physical substrate during the process of 
Notch signaling, because the Notch ligand must be immobilized. During the first step in Notch 
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ligand sensing, the receptor binds to the ligand and the force results in a cleavage event in the 
extracellular portion of the receptor. Because of this, it is reasonable to believe that 
mechanotransduction could be a part of the Notch transduction pathway. Thus, mimicking 
thymic mechanical properties could significantly increase T cell differentiation potential.  
 Unfortunately, current methods of in vitro T cell differentiation are neither three-
dimensional nor are they of suitable material stiffness. One current method of in vitro T cell 
differentiation involves growing stem cells on a modified layer of stromal cells derived from the 
bone marrow that has been transfected with DLL4 to induce T cell differentiation. Another 
isolates DLL4 and independently binds the ligand to tissue culture treated plates to promote 
Notch signaling and T cell lineage commitment. Neither are adequate simulations of the thymic 
microenvironment. 
 To this end, this study presents two differentiation protocols that improve synthetic 
conditions using biomaterials, or materials that can interface with biological systems. One 
substrate is an ordered, porous scaffold called an inverse opal structure made from PEGDA. The 
other is a two-dimensional gel with finely tunable mechanical properties composed of PA. 
Because the pores in the PEGDA IO scaffolds collapse if the gel is too soft, this study does not 
present a system that solves both the three-dimensional problem and the problem of the tunable 
mechanical environment. Instead, model systems explore each variable independently. 
 Data presented above demonstrate that both the PEGDA IO and 2D PA systems provide 
intricate control over the chemical microenvironment. Chemical connection systems have been 
developed to present streptavidin on the surfaces of functionalized polymer gels that can then be 
bound to biotin-modified DLL4. Incubating with higher concentrations of streptavidin and/or 
biotin result in higher final spatial densities of DLL4 on the polymer surface. Thus, the chemical 
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microenvironment can be finely tuned to develop any density of DLL4 between zero and the 
saturation point on the gel, a point that was never reached in the experiments described here. 
 Similarly, the mechanical properties of the 2D PA gel system can be tightly controlled by 
modifying the amount of acrylamide versus bis-acrylamide, the two monomer types in the PA 
chain. Rheological studies demonstrated that 4% acrylamide, 0.04% bis-acrylamide gels 
accurately mimic the mechanical properties of the thymus, which has a storage modulus of 
approximately 110 Pa. These gels can be made more or less stiff by increasing or decreasing the 
concentration of acrylamide and bis-acrylamide, respectively. Importantly, modifying the 
stiffness of the gel does not affect the density of ligand that can be bound. Thus, for the 2D PA 
system, mechanical stiffness and ligand density are orthogonal systems each independently 
tunable for optimization. 
 Although PEGDA scaffolds could not be mechanically modified to the same extent as 2D 
PA gels, rheological studies were also performed to elucidate their mechanical strength. The 
concentration of PEGDA used in this study (40%) yielded a storage modulus several orders of 
magnitude higher than that of the thymus or 4% PA gels, averaging at approximately 7000 Pa. 
However, this elasticity is still a significant improvement over traditional polystyrene surfaces, 
which have elastic moduli on the order of GPa. Thus, even though the 3D PEGDA system 
suffers from a lack of mechanical tunability, it still offers compliance far closer to the thymus 
than customary tissue culture practice. 
 None of the attempts to mimic the thymus are meaningful, however, unless they 1) 
successfully induce Notch signaling and 2) result in T cell differentiation. The most promising 
Notch signaling data collected thus far is with the 3D PEGDA scaffolds, which show a clear 
dose dependency in levels of Hes-1 expression following incubation of cells in functionalized 
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scaffolds for three hours. The clear relationship between ligand density and Notch signaling was 
absent when cells were instead seeded on 2D softer surfaces. On one hand, this indicates that the 
tunability of the PA system is somewhat lacking, because although ligand density can be finely 
regulated, this does not translate into effective control over the level of Notch signaling. On the 
other hand, however, the basal level of Notch signaling on soft 4% PA surfaces that mimic the 
mechanics of the thymus (~2.5 fold above the control) is comparable to the high levels of Notch 
signaling induced on the slightly harder 3D surfaces with the highest density of Notch ligand 
(~2.75 fold above the control). 
 The idea that soft surfaces can induce basal levels of Notch signaling is an interesting one 
that has not yet been explored in the literature. Further mechanical studies on the molecular 
interactions between ligand-bearing stromal cells and receptor-bearing progenitor cells in vivo 
must be conducted to determine whether there is a causal relationship between mechanical 
properties and Notch induction or whether the observed apparent relationship is instead due to 
some other variable that has not been controlled in this study. 
 Finally, differentiation data was collected for lin-ckit+sca1+ cells cultured on 2D PA gels 
with a cytokine cocktail designed for expansion and differentiation. After nine days of culture, 
about 3% of the cells had a Thy1.2+CD25+ double-positive phenotype indicative of early T cells. 
This efficiency is relatively low compared to other in vitro T cell differentiation systems that 
have been developed. In their studies using OP9-DL1 co-culture, the Zúñiga-Pflücker group 
reports nearly 95% CD25 expression, whereas the experiments described above produced 
roughly 4% CD25. Differentiation on 2D PA gels also yields high numbers of CD44+CD25- cells 
(data not shown), indicative of the DN1 stage in development, whereas CD25 expression is 
indicative of DN2 and DN2 expression. Thus, compared to the Zúñiga-Pflücker method, the soft-
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substrate differentiation strategy appears to arrest the cells at an earlier stage in  development. 
The Varnum-Finney group has also reported highly efficient T cell differentiation using 
immobilized ligands on tissue culture treated polystyrene surfaces. They report plots where 
>50% of the cells are Thy1.2+CD25+ double positive. However, it should be noted that these 
results were measured after three weeks of culture, versus culture just over one week on soft 
surfaces.  
 These data indicate that further optimization may be required to induce differentiation 
beyond the DN1 stage in development. Nonetheless, the systems presented in this thesis have 
clear advantages. First, the creation of highly porous 3D systems potentially allows for much 
more robust scale-up in the future. These scaffolds have significantly higher spatial efficiency 
than conventional tissue culture flasks. If the dream of creating a bank of T cells is to be realized, 
using porous ex vivo scaffold technology would be a far more space-efficient means of growing, 
cultivating, and differentiating cells prior to re-implantation into the immunocompromised host. 
Second, although the 2D PA system seems less effective at inducing efficient T cell 
differentiation, it provides a novel means to study the effects of mechanical properties on 
differentiation, which may be critical to further research in the field. Results hint at a non-
canonical form of Notch signaling that should be further explored. 
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6. Conclusions 	  	   	   The data described in this thesis indicate that soft polymer systems can be developed to 
mimic the thymic microenvironment both chemically and mechanically. These include a 
polyacrylamide two-dimensional system and a porous three-dimensional poly(ethylene glycol) 
system. Furthermore, these systems are suitable as substrates for cell growth and differentiation. 
Studies presented above show that the polymers can be chemically modified to be bioactive. 
Ligands, or biological signals, can be attached in a reliable fashion, and used to direct stem cells 
down a particular differentiation pathway. Gene expression studies indicate that when ligands 
responsible for Notch signaling—the key signaling event in early T cell differentiation—are 
chemically bound to these polymer surfaces, they increase the expression of genes downstream 
in the Notch signaling pathway. These short-term studies have also been translated into long-
term differentiation studies, and functionalized polyacrylamide has been shown to produce early-
stage T cells. Together, these results demonstrate the potential that biomaterials have in the field 
of immunotherapy, in particular in the differentiation of T cells from stem cells. 	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